Overview

Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain

Status:
Terminated

Trial end date:
2017-04-26

Target enrollment:

Participant gender:

Summary

Phase 4, multicenter, open-label, multiple-dose study of the pharmacokinetics (PK) and safety of XARTEMIS XR in postsurgical adolescent subjects aged 12 to 17 years with moderate to severe acute pain. The study will assess the safety of administering multiple doses of XARTEMIS XR in this population.

Phase:

Phase 4

Details

Lead Sponsor:

Mallinckrodt

Treatments:

Acetaminophen
Acetaminophen, hydrocodone drug combination
Oxycodone